...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Down 53% today

"ZHCLF 53% drop today, what's up?"

 

McCaffreys wage & compensation is all i can think of.

Share
New Message
Please login to post a reply